Nasdaq · CIK 0001761612
BCYC BICYCLE THERAPEUTICS PLC
Insider trading from SEC Form 4. Last filing Mar 27, 2025. Close $3.89 on Oct 9, 2026, +15% from the 52-week low and -56% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
17
with a Form 4 at this company
Price and insider trades, last year
Signals
Open-market buys and sells at BICYCLE THERAPEUTICS PLC, scored.
| Score | Side | Insider | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 38Weak | sell 8 | Arroyo Santiago CHIEF DEVELOPMENT OFFICER | $70k | 4,943 | -7% | +4% from low · -48% from high | |
| 51Moderate | sell 8 | Lee Kevin CHIEF EXECUTIVE OFFICER | $173k | 12,130 | -2% | +4% from low · -48% from high | |
| 35Weak | sell 8 | Hannay Michael Charles Ferguson CHIEF PROD & SUPPLY CHAIN OFF | $30k | 2,118 | -4% | +4% from low · -48% from high | |
| 37Weak | sell 8 | Skynner Michael CHIEF TECHNOLOGY OFFICER | $60k | 4,223 | -3% | +4% from low · -48% from high | |
| 44Moderate | sell 8 | Milnes Alistair CHIEF OPERATING OFFICER | $78k | 5,514 | -5% | +4% from low · -48% from high | |
| 37Weak | sell 8 | Crockett Nigel CHIEF BUSINESS OFFICER | $50k | 3,519 | -6% | +4% from low · -48% from high | |
| 37Weak | sell 8 | Young Alethia Chief Financial Officer | $20k | 1,395 | -3% | +4% from low · -48% from high | |
| 23Weak | sell 810b5-1 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | $67k | 4,595 | -13% | +4% from low · -48% from high | |
| 50Moderate | buy | BAKER BROS. ADVISORS LP director, owner | $21M | 1,485,397 | +189% | - | |
| 1Weak | sell10b5-1 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | $157k | 6,256 | -26% | - |
Transactions
The last 72 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 25, 2025 | Riva Alessandro director | AGrant or award Ordinary Shares | +12,500 | $0.00 | $0 | 12,500 | Mar 27, 2025 |
| Mar 25, 2025 | Westin Eric Chief Medical Officer | AGrant or award Employee Stock Option (right to buy)derivative | +58,000 | $0.00 | $0 | 58,000 | Mar 27, 2025 |
| Mar 25, 2025 | Riva Alessandro director | AGrant or award Stock Option (right to buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Mar 27, 2025 |
| Jan 2, 2025 | Milnes Alistair CHIEF OPERATING OFFICER | AGrant or award Ordinary Shares | +35,000 | $0.00 | $0 | 105,302 | Jan 6, 2025 |
| Jan 2, 2025 | Legault Pierre director | AGrant or award Ordinary Shares | +12,500 | $0.00 | $0 | 46,000 | Jan 6, 2025 |
| Jan 2, 2025 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | AGrant or award Ordinary Shares10b5-1 | +17,500 | $0.00 | $0 | 36,741 | Jan 6, 2025 |
| Jan 2, 2025 | Young Alethia Chief Financial Officer | AGrant or award Ordinary Shares | +35,000 | $0.00 | $0 | 47,000 | Jan 6, 2025 |
| Jan 2, 2025 | Crockett Nigel CHIEF BUSINESS OFFICER | AGrant or award Ordinary Shares | +8,750 | $0.00 | $0 | 54,572 | Jan 6, 2025 |
| Jan 2, 2025 | Skynner Michael CHIEF TECHNOLOGY OFFICER | AGrant or award Ordinary Shares | +35,000 | $0.00 | $0 | 127,945 | Jan 6, 2025 |
| Jan 2, 2025 | Hannay Michael Charles Ferguson CHIEF PROD & SUPPLY CHAIN OFF | AGrant or award Ordinary Shares | +35,000 | $0.00 | $0 | 57,398 | Jan 6, 2025 |
| Jan 2, 2025 | Lee Kevin CHIEF EXECUTIVE OFFICER | AGrant or award Ordinary Shares | +123,200 | $0.00 | $0 | 504,064 | Jan 6, 2025 |
| Jan 2, 2025 | Winter Gregory Paul director | AGrant or award Ordinary Shares | +6,250 | $0.00 | $0 | 186,927 | Jan 6, 2025 |
| Jan 2, 2025 | Sands Stephen H. director | AGrant or award Ordinary Shares | +5,393 | $0.00 | $0 | 17,393 | Jan 6, 2025 |
| Jan 2, 2025 | Kender Richard N director | AGrant or award Ordinary Shares | +6,250 | $0.00 | $0 | 23,000 | Jan 6, 2025 |
| Jan 2, 2025 | Gutierrez-Ramos Jose-Carlos director | AGrant or award Ordinary Shares | +6,250 | $0.00 | $0 | 23,000 | Jan 6, 2025 |
| Jan 2, 2025 | Bourque Janice director | AGrant or award Ordinary Shares | +6,250 | $0.00 | $0 | 23,000 | Jan 6, 2025 |
| Jan 2, 2025 | Arroyo Santiago CHIEF DEVELOPMENT OFFICER | AGrant or award Ordinary Shares | +35,000 | $0.00 | $0 | 74,000 | Jan 6, 2025 |
| Jan 2, 2025 | BAKER BROS. ADVISORS LP director, owner | AGrant or award American Depositary Sharesindirect: See Footnotes | +4,400 | $0.00 | $0 | 918,483 | Jan 6, 2025 |
| Jan 2, 2025 | Milnes Alistair CHIEF OPERATING OFFICER | SOpen-market sale Ordinary Shares | -4,578 | $14.09 | $65k | 100,724 | Jan 6, 2025 |
| Jan 2, 2025 | Crockett Nigel CHIEF BUSINESS OFFICER | SOpen-market sale Ordinary Shares | -2,583 | $14.09 | $36k | 51,989 | Jan 6, 2025 |
| Jan 2, 2025 | Skynner Michael CHIEF TECHNOLOGY OFFICER | SOpen-market sale Ordinary Shares | -3,287 | $14.09 | $46k | 124,658 | Jan 6, 2025 |
| Jan 2, 2025 | Young Alethia Chief Financial Officer | SOpen-market sale Ordinary Shares | -1,395 | $14.09 | $20k | 45,605 | Jan 6, 2025 |
| Jan 2, 2025 | Hannay Michael Charles Ferguson CHIEF PROD & SUPPLY CHAIN OFF | SOpen-market sale Ordinary Shares | -1,879 | $14.09 | $26k | 55,519 | Jan 6, 2025 |
| Jan 2, 2025 | Lee Kevin CHIEF EXECUTIVE OFFICER | SOpen-market sale Ordinary Shares | -9,038 | $14.09 | $127k | 495,026 | Jan 6, 2025 |
| Jan 2, 2025 | Winter Gregory Paul director | AGrant or award Stock Option (right to buy)derivative | +12,500 | $0.00 | $0 | 12,500 | Jan 6, 2025 |
| Jan 2, 2025 | BAKER BROS. ADVISORS LP director, owner | AGrant or award American Depositary Sharesindirect: See Footnotes | +4,400 | $0.00 | $0 | 9,999,674 | Jan 6, 2025 |
| Jan 2, 2025 | Sands Stephen H. director | AGrant or award Stock Option (right to buy)derivative | +10,787 | $0.00 | $0 | 10,787 | Jan 6, 2025 |
| Jan 2, 2025 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | SOpen-market sale Ordinary Shares10b5-1 | -1,750 | $14.09 | $25k | 34,991 | Jan 6, 2025 |
| Jan 2, 2025 | Kender Richard N director | AGrant or award Stock Option (right to buy)derivative | +12,500 | $0.00 | $0 | 12,500 | Jan 6, 2025 |
| Jan 2, 2025 | Legault Pierre director | AGrant or award Stock Option (right to buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Jan 6, 2025 |
| Jan 2, 2025 | Gutierrez-Ramos Jose-Carlos director | AGrant or award Stock Option (right to buy)derivative | +12,500 | $0.00 | $0 | 12,500 | Jan 6, 2025 |
| Jan 2, 2025 | Bourque Janice director | AGrant or award Stock Option (right to buy)derivative | +12,500 | $0.00 | $0 | 12,500 | Jan 6, 2025 |
| Jan 2, 2025 | Arroyo Santiago CHIEF DEVELOPMENT OFFICER | SOpen-market sale Ordinary Shares | -4,943 | $14.09 | $70k | 69,057 | Jan 6, 2025 |
| Jan 3, 2025 | Lee Kevin CHIEF EXECUTIVE OFFICER | SOpen-market sale Ordinary Shares | -3,092 | $14.75 | $46k | 491,934 | Jan 6, 2025 |
| Jan 2, 2025 | Arroyo Santiago CHIEF DEVELOPMENT OFFICER | AGrant or award Employee Stock Option (right to buy)derivative | +87,000 | $0.00 | $0 | 87,000 | Jan 6, 2025 |
| Jan 3, 2025 | Hannay Michael Charles Ferguson CHIEF PROD & SUPPLY CHAIN OFF | SOpen-market sale Ordinary Shares | -239 | $14.75 | $3,525 | 55,280 | Jan 6, 2025 |
| Jan 3, 2025 | Skynner Michael CHIEF TECHNOLOGY OFFICER | SOpen-market sale Ordinary Shares | -936 | $14.75 | $14k | 123,722 | Jan 6, 2025 |
| Jan 2, 2025 | Young Alethia Chief Financial Officer | AGrant or award Employee Stock Option (right to buy)derivative | +87,000 | $0.00 | $0 | 87,000 | Jan 6, 2025 |
| Jan 3, 2025 | Milnes Alistair CHIEF OPERATING OFFICER | SOpen-market sale Ordinary Shares | -936 | $14.75 | $14k | 99,788 | Jan 6, 2025 |
| Jan 3, 2025 | Crockett Nigel CHIEF BUSINESS OFFICER | SOpen-market sale Ordinary Shares | -936 | $14.75 | $14k | 51,053 | Jan 6, 2025 |
| Jan 3, 2025 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | SOpen-market sale Ordinary Shares10b5-1 | -159 | $14.75 | $2,345 | 34,832 | Jan 6, 2025 |
| Jan 2, 2025 | BAKER BROS. ADVISORS LP director, owner | AGrant or award Share Option (Right to Buy)derivativeindirect: See Footnotes | +8,801 | $0.00 | $0 | 8,801 | Jan 6, 2025 |
| Jan 2, 2025 | Skynner Michael CHIEF TECHNOLOGY OFFICER | AGrant or award Employee Stock Option (right to buy)derivative | +87,000 | $0.00 | $0 | 87,000 | Jan 6, 2025 |
| Jan 2, 2025 | Crockett Nigel CHIEF BUSINESS OFFICER | AGrant or award Employee Stock Option (right to buy)derivative | +21,750 | $0.00 | $0 | 21,750 | Jan 6, 2025 |
| Jan 2, 2025 | Hannay Michael Charles Ferguson CHIEF PROD & SUPPLY CHAIN OFF | AGrant or award Employee Stock Option (right to buy)derivative | +87,000 | $0.00 | $0 | 87,000 | Jan 6, 2025 |
| Jan 2, 2025 | Lee Kevin CHIEF EXECUTIVE OFFICER | AGrant or award Employee Stock Option (right to buy)derivative | +308,000 | $0.00 | $0 | 308,000 | Jan 6, 2025 |
| Jan 6, 2025 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | SOpen-market sale Ordinary Shares10b5-1 | -2,686 | $15.00 | $40k | 32,146 | Jan 6, 2025 |
| Jan 2, 2025 | BAKER BROS. ADVISORS LP director, owner | AGrant or award Share Option (Right to Buy)derivativeindirect: See Footnotes | +8,801 | $0.00 | $0 | 8,801 | Jan 6, 2025 |
| Jan 2, 2025 | Milnes Alistair CHIEF OPERATING OFFICER | AGrant or award Employee Stock Option (right to buy)derivative | +87,000 | $0.00 | $0 | 87,000 | Jan 6, 2025 |
| Jan 2, 2025 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | AGrant or award Employee Stock Option (right to buy)derivative10b5-1 | +43,500 | $0.00 | $0 | 43,500 | Jan 6, 2025 |
| Dec 13, 2024 | BAKER BROS. ADVISORS LP director, owner | POpen-market purchase American Depositary Sharesindirect: See Footnotes | +2,809 | $13.50 | $38k | 790,763 | Dec 17, 2024 |
| Dec 13, 2024 | BAKER BROS. ADVISORS LP director, owner | POpen-market purchase American Depositary Sharesindirect: See Footnotes | +30,241 | $13.50 | $408k | 8,666,247 | Dec 17, 2024 |
| Dec 13, 2024 | BAKER BROS. ADVISORS LP director, owner | POpen-market purchase American Depositary Sharesindirect: See Footnotes | +5,573 | $13.63 | $76k | 796,336 | Dec 17, 2024 |
| Dec 13, 2024 | BAKER BROS. ADVISORS LP director, owner | POpen-market purchase American Depositary Sharesindirect: See Footnotes | +59,995 | $13.63 | $818k | 8,726,242 | Dec 17, 2024 |
| Dec 13, 2024 | BAKER BROS. ADVISORS LP director, owner | POpen-market purchase American Depositary Sharesindirect: See Footnotes | +22,722 | $13.72 | $312k | 819,058 | Dec 17, 2024 |
| Dec 13, 2024 | BAKER BROS. ADVISORS LP director, owner | POpen-market purchase American Depositary Sharesindirect: See Footnotes | +244,587 | $13.72 | $3.4M | 8,970,829 | Dec 17, 2024 |
| Dec 13, 2024 | BAKER BROS. ADVISORS LP director, owner | POpen-market purchase American Depositary Sharesindirect: See Footnotes | +52,656 | $13.80 | $727k | 871,714 | Dec 17, 2024 |
| Dec 13, 2024 | BAKER BROS. ADVISORS LP director, owner | POpen-market purchase American Depositary Sharesindirect: See Footnotes | +566,814 | $13.80 | $7.8M | 9,537,643 | Dec 17, 2024 |
| Dec 16, 2024 | BAKER BROS. ADVISORS LP director, owner | POpen-market purchase American Depositary Sharesindirect: See Footnotes | +42,369 | $15.34 | $650k | 914,083 | Dec 17, 2024 |
| Dec 16, 2024 | BAKER BROS. ADVISORS LP director, owner | POpen-market purchase American Depositary Sharesindirect: See Footnotes | +457,631 | $15.34 | $7.0M | 9,995,274 | Dec 17, 2024 |
| Nov 11, 2024 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | MOption exercise Ordinary Shares10b5-1 | +1,312 | $1.87 | $2,453 | 24,234 | Nov 13, 2024 |
| Nov 11, 2024 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | SOpen-market sale Ordinary Shares10b5-1 | -1,312 | $25.05 | $33k | 22,922 | Nov 13, 2024 |
| Nov 11, 2024 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | MOption exercise Ordinary Shares10b5-1 | +154 | $8.21 | $1,264 | 23,076 | Nov 13, 2024 |
| Nov 11, 2024 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | SOpen-market sale Ordinary Shares10b5-1 | -154 | $25.01 | $3,852 | 22,922 | Nov 13, 2024 |
| Nov 11, 2024 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | MOption exercise Ordinary Shares10b5-1 | +1,109 | $9.82 | $11k | 24,031 | Nov 13, 2024 |
| Nov 11, 2024 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | SOpen-market sale Ordinary Shares10b5-1 | -1,109 | $25.05 | $28k | 22,922 | Nov 13, 2024 |
| Nov 11, 2024 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | SOpen-market sale Ordinary Shares10b5-1 | -3,241 | $25.21 | $82k | 19,681 | Nov 13, 2024 |
| Nov 11, 2024 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | SOpen-market sale Ordinary Shares10b5-1 | -209 | $24.77 | $5,177 | 19,472 | Nov 13, 2024 |
| Nov 11, 2024 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | SOpen-market sale Ordinary Shares10b5-1 | -231 | $24.82 | $5,733 | 19,241 | Nov 13, 2024 |
| Nov 11, 2024 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -1,312 | $0.00 | $0 | 2,617 | Nov 13, 2024 |
| Nov 11, 2024 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -154 | $0.00 | $0 | 302 | Nov 13, 2024 |
| Nov 11, 2024 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -1,109 | $0.00 | $0 | 12,954 | Nov 13, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Arroyo SantiagoCHIEF DEVELOPMENT OFFICER
- BAKER BROS. ADVISORS LPdirector, owner
- Bourque Janicedirector
- Crockett NigelCHIEF BUSINESS OFFICER
- Gutierrez-Ramos Jose-Carlosdirector
- Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF
- Kender Richard Ndirector
- Lee KevinCHIEF EXECUTIVE OFFICER
- Legault Pierredirector
- Milnes AlistairCHIEF OPERATING OFFICER
- Riva Alessandrodirector
- Sands Stephen H.director
- Skynner MichaelCHIEF TECHNOLOGY OFFICER
- Thompson Travis AlvinCHIEF ACCOUNTING OFFICER
- Westin EricChief Medical Officer
- Winter Gregory Pauldirector
- Young AlethiaChief Financial Officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.